Related Experiment Videos
Abnormal nerve conduction in impotent patients with diabetes mellitus
1Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri.
Diabetes Care
|July 1, 1989
Summary
Diabetic impotence is often caused by nerve damage, not blood flow issues. Measuring bulbocavernosus-reflex latency time effectively diagnoses pelvic nerve dysfunction in diabetic men.
Area of Science:
- Urology
- Endocrinology
- Neuroscience
Background:
- Erectile dysfunction (ED) is a common complication in diabetic patients.
- The precise causes of ED in diabetes remain incompletely understood.
- Distinguishing between vascular and neurological origins of ED is crucial for effective treatment.
Purpose of the Study:
- To investigate the underlying causes of impotence in diabetic individuals.
- To compare penile vascular and neurological function between impotent and non-impotent diabetic men.
- To identify reliable diagnostic markers for diabetic-associated erectile dysfunction.
Main Methods:
- Nocturnal penile tumescence and rigidity monitoring.
- Assessment of penile arterial blood flow using penile brachial index.
- Evaluation of pudendal nerve conduction via bulbocavernosus-reflex latency time measurement.
- Comparison between impotent diabetics, non-impotent diabetics, and psychogenic impotence controls.
Main Results:
- No significant difference in penile brachial index between impotent and non-impotent diabetic groups.
- Significant abnormalities in nocturnal erection monitoring observed in all impotent diabetic subjects.
- Markedly prolonged bulbocavernosus-reflex latency times in impotent diabetic subjects compared to non-impotent diabetics (48.4 ms vs. 38.7 ms).
Conclusions:
- Diabetic impotence is primarily attributed to functional abnormalities of pelvic nerves.
- Bulbocavernosus-reflex latency time is a highly sensitive diagnostic tool for assessing pelvic nerve function in diabetic patients.
- This finding aids in differentiating the etiology of erectile dysfunction in the diabetic population.